Abbott Laboratories (ABT) Construction in Progress (2009 - 2025)
Abbott Laboratories (ABT) reported Construction in Progress of $2.6 billion for Q4 2025, up 3.18% on a YoY basis from $2.5 billion in Q4 2024, and up 3.18% sequentially from $2.5 billion in Q4 2024.
Abbott Laboratories (ABT) Construction in Progress (2009 - 2025) Analysis & Trends
Abbott Laboratories (ABT) has 17 years of Construction in Progress data on file, last reported at $2.6 billion in Q4 2025.
- For the quarter ending Q4 2025, Construction in Progress rose 3.18% year-over-year to $2.6 billion; the trailing twelve-month figure through Dec 2025 stood at $2.6 billion (up 3.18% YoY), and the FY2025 full-year result was $2.6 billion, up 3.18% from the prior year.
- Construction in Progress grew to $2.6 billion in Q4 2025, from $2.5 billion in the prior quarter.
- In the past five years, Construction in Progress ranged from a high of $2.6 billion in Q4 2025 to a low of $1.3 billion in Q4 2021.
- A 5-year average of $2.0 billion and a median of $2.1 billion in 2023 frame the typical range for Construction in Progress.
- Across the five-year window, Construction in Progress retreated 3.91% in 2021 and soared 39.08% in 2023, its largest moves.
- Tracing ABT's Construction in Progress over 5 years: stood at $1.3 billion in 2021, then rose by 13.8% to $1.5 billion in 2022, then soared by 39.08% to $2.1 billion in 2023, then gained by 20.54% to $2.5 billion in 2024, then gained by 3.18% to $2.6 billion in 2025.
- Business Quant data shows ABT's Construction in Progress at $2.6 billion in Q4 2025, $2.5 billion in Q4 2024, and $2.1 billion in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.12 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 509.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.57 Bn |
| Dec 31, 2024 | 2.49 Bn |
| Dec 31, 2023 | 2.06 Bn |
| Dec 31, 2022 | 1.48 Bn |
| Dec 31, 2021 | 1.30 Bn |
| Dec 31, 2020 | 1.36 Bn |
| Dec 31, 2019 | 1.11 Bn |
| Dec 31, 2018 | 894.00 Mn |
| Dec 31, 2017 | 732.00 Mn |
| Dec 31, 2016 | 962.00 Mn |
| Dec 31, 2015 | 928.00 Mn |
| Dec 31, 2014 | 727.00 Mn |
| Dec 31, 2013 | 868.00 Mn |
| Dec 31, 2012 | 954.00 Mn |
| Dec 31, 2011 | 698.87 Mn |
| Dec 31, 2010 | 577.46 Mn |
| Dec 31, 2009 | 604.81 Mn |